Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Evive and Nona Partner Up to Develop Antibody Drugs

publication date: Dec 13, 2023

Evive Biotech, a Yifan Pharma subsidiary developing novel biological drugs, formed an antibody discovery collaboration using Boston’s Nona Biosciences Harbour Mice® antibody technology platform. The two companies will work together to accelerate the process of antibody discovery and drug development. Founded in 2004, Evive intends to bring innovative drugs from China to the world. The company applies its proprietary technology platforms to advance innovative drug candidates for oncology, inflammatory and metabolic diseases. Nona is a wholly-owned subsidiary of HBM Holdings, which has its headquarters in Boston with drug discovery operations in Rotterdam and laboratories in Shanghai. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital